The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
UAE welcomes US removal of Syria from terrorism list
Dubai completes road improvements across six school zones
UAE leaders reflect on Prophet Muhammad's legacy
Dubai Police warns of fake social media ads offering visas for money
Sheikh Abdullah congratulates Peruvian FM on appointment
